Skip to content
2000
Volume 11, Issue 3
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Metabolic syndrome as a clustering of risk factors for diabetes and cardiovascular disease affects both men and women, but with important gender differences. Animal models have been used to understand disease progression and define therapeutic options, but most pre-clinical research on metabolic syndrome is undertaken in males. This opinion piece discusses the differences in male and female physiology that may influence both the development and the responses to pharmacological interventions of metabolic disorders, especially obesity. An appreciation of gender differences should improve the design and usefulness of biomedical experimental research to allow the development of relevant genderbased treatment options for chronic diseases including obesity, metabolic and cardiovascular diseases.

Loading

Article metrics loading...

/content/journals/emiddt/10.2174/187153011796429808
2011-09-01
2025-05-23
Loading full text...

Full text loading...

/content/journals/emiddt/10.2174/187153011796429808
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test